Phosphoproteome analysis of formalin-fixed and paraffin-embedded tissue sections mounted on microscope slides

Masaki Wakabayashi1, Hiroki Yoshihara, Takeshi Masuda

  • 1Graduate School of Pharmaceutical Sciences, Kyoto University , Sakyo-ku, Kyoto 606-8501, Japan.

Insights

This study introduces a novel method for quantitative phosphoproteome analysis in formalin-fixed, paraffin-embedded (FFPE) tissue sections. The new protocol enables detailed phosphorylation profiling from archival slides, crucial for retrospective disease research.

Area of Science:

  • Proteomics
  • Biochemistry
  • Pathology

Background:

  • Formalin-fixed, paraffin-embedded (FFPE) tissue sections are valuable for retrospective disease research.
  • Quantitative phosphoproteome analysis of FFPE sections has been challenging due to limited protein and phosphopeptide yields.

Purpose of the Study:

  • To develop the first protocol for quantitative phosphoproteome analysis of FFPE tissue sections.
  • To enable comprehensive phosphorylation profiling from archival FFPE slides for disease research.

Main Methods:

  • Phase-transfer surfactant-aided extraction and tryptic digestion of FFPE proteins.
  • High-recovery phosphopeptide enrichment using lactic acid-modified titania chromatography.
  • Chemical labeling via reductive dimethylation and enhanced LC-MS sensitivity with miniaturized nanoLC columns.

Main Results:

  • Successfully established a protocol for quantitative phosphoproteome analysis of FFPE sections.
  • Demonstrated that FFPE sections maintain a stable phosphoproteome for at least 9 months.
  • Identified 1090 phosphopeptides from a single FFPE section using the developed method.

Conclusions:

  • The developed protocol is the first to enable quantitative phosphoproteome analysis of FFPE sections.
  • This method is suitable for evaluating phosphorylation profiles in various diseases using archival FFPE slides.
  • The protocol facilitates large-scale phosphoproteome analysis, particularly for scarce samples like those from rare diseases.